CRAIG B. SHAFFER, Magistrate Judge.
This matter comes before the court on Defendant Pfizer Inc.'s ("Pfizer") Motion to Dismiss (Doc. #30) for failure to state a claim, filed on March 3, 2015. This motion was referred to the Magistrate Judge pursuant to the Order of Reference dated January 21, 2015 (Doc. #18). The court has carefully considered the motion and related briefing, the entire case file, the comments offered by the parties during the telephonic status conference on March 18, 2015 (Doc. #32), and the applicable case law. For the following reasons, I recommend that Defendant's Motion to Dismiss be granted with prejudice.
This action is Plaintiffs Donald and Donna Meyers' second attempt to hold Defendant Pfizer liable for side effects allegedly caused by the drug Lipitor. Plaintiffs, appearing pro se, initiated the current action on October 31, 2014, by filing their Complaint (Doc. #1) and one Motion to Proceed in District Court Without Prepaying Fees or Costs (Doc. #3). These documents were only signed by Mr. Meyers. On November 6, 2014, Plaintiffs were directed to (1) submit an application to proceed without payment on behalf of Mrs. Meyers and a Complaint signed by both Plaintiffs; (2) provide addresses of named Defendants; and (3) complete all necessary sections of the Court-approved Complaint form. (Doc. #5). Plaintiffs filed their Amended Complaint on November 17, 2014. (Doc. #7).
Subsequently, the court issued an Order directing Plaintiffs to show cause as to why the Amended Complaint should not be dismissed as time-barred. (Doc. #12). Plaintiffs submitted a Response on December 17, 2014. (Doc. #15). The court issued an Order Assigning Case (Doc. #16) on January 20, 2015.
Plaintiffs assert that Mrs. Meyers took the drug Lipitor (which is manufactured by Pfizer) from 2002 to 2008, and as a result, she allegedly suffers from memory loss, impairment of cognitive abilities, and sudden mood changes. (Doc. #7). Plaintiffs further allege that Mrs. Meyers's doctor informed them numerous times that Lipitor carried no warnings regarding these side effects. (Id.). In September 2010, Mr. Meyers complained to Pfizer. Pfizer responded that Lipitor had no known side effects like those Mrs. Meyers was experiencing. (Id.). From February 2011 to June 2011, Mr. Meyers consulted two attorneys regarding a claim against Pfizer. (Letter from Plaintiff at 1, filed as Doc. #29 in Meyers v. Pfizer, No. 13-cv-1508-WJM-CBS). Because Mrs. Meyers stopped taking the medication no later than 2008, both attorneys advised Mr. Meyers that his wife's claim would be barred by the statute of limitations. (Id.).
Thereafter, on or about March 1, 2012, the Food and Drug Administration ("FDA") allegedly mandated that drugs like Lipitor carry a warning regarding side effects like those Mrs. Meyers was experiencing. (Doc. #7). Mr. Meyers believed the two-year statute of limitations started accruing again once the FDA released this requirement. (Letter from Plaintiff at 1, filed as Doc. #29 in Meyers v. Pfizer, No. 13-cv-1508-WJM-CBS). Following the FDA's announcement, Mr. Meyers attempted to hire legal counsel to pursue a claim against Pfizer with no success. Fifteen months later, on June 12, 2013, Mr. Meyers initiated the original case against Pfizer. (Complaint at 1, filed as Doc. #1 in Meyers v. Pfizer, No. 13-cv-1508-WJM-CBS).
Mr. Meyers failed to file proof of proper service of the original Complaint, and despite being advised of this, he did nothing to cure the problem. On February 10, 2014, Plaintiff expressed his desire to withdraw the lawsuit to correct any deficiencies and then refile a new action before the two-year statute of limitations ran out on March 1, 2014. (Motion to Withdraw Case at 1, filed as Doc. #43 in Meyers v. Pfizer, No. 13-cv-1508-WJM-CBS). On March 4, 2014, the court ordered Plaintiff to properly file a Notice of Dismissal under Rule 41(a)(1)(a). (Minute Order at 1, filed as Doc. #47 in Meyers v. Pfizer, No. 13-cv-1508-WJM-CBS). Plaintiff never filed such motion, and the case was dismissed for insufficient service. Meyers v. Pfizer, No. 13-cv-1508-WJM-CBS, 2014 WL 2490158 (D. Colo. June 2, 2014). The dismissal was affirmed by the Tenth Circuit. Meyers v. Pfizer, Inc., 581 Fed. Appx. 708, 711 (10th Cir. 2014).
The following month, Plaintiffs filed the current action and their Complaint seeking monetary damages related to the alleged injuries suffered by Mrs. Meyers. (Doc. #1). On March 3, 2015, Defendant Pfizer moved to dismiss (Doc. #30) on the ground that Plaintiffs' claims are time-barred under the applicable two-year statute of limitations. Plaintiffs filed a Response (Doc. #33) to the Motion on April 3, 2015. Defendant filed a Reply (Doc. #34) on April 15, 2015, and Plaintiffs filed a Surreply (Doc. #35) on April 27, 2015.
Under Rule 12(b)(6) a court may dismiss a complaint for "failure to state a claim upon which relief can be granted." Fed. R. Civ. P. 12(b)(6). In deciding a motion under Rule 12(b)(6), the court must "accept as true all well-pleaded factual allegations . . . and view these allegations in the light most favorable to the Plaintiff." Casanova v. Ulibarri, 595 F.3d 1120, 1124 (10th Cir. 2010) (quoting Smith v. United States, 561 F.3d 1090, 1098 (10th Cir. 2009)). However, a Plaintiff may not rely on mere labels or conclusions, "and a formulaic recitation of the elements of a cause of action will not do." Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007).
"To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to state a claim to relief that is plausible on its face." Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). As the Tenth Circuit explained in Ridge at Red Hawk, L.L.C. v. Schneider, 493 F.3d 1174, 1177 (10th Cir. 2007), "the mere metaphysical possibility that some Plaintiff could prove some set of facts in support of the pleaded claims is insufficient; the complaint must give the court reason to believe that this Plaintiff has a reasonable likelihood of mustering factual support for these claims." A plaintiff bears the burden of coming forward with "`enough factual matter (taken as true) to suggest' that he or she is entitled to relief." Robbins v. Oklahoma, 519 F.3d 1242, 1247 (10th Cir. 2008) (quoting Bell Atlantic Corp., 550 U.S. at 556). The ultimate duty of the court is to "determine whether the complaint sufficiently alleges facts supporting all the elements necessary to establish an entitlement to relief under the legal theory proposed." Forest Guardians v. Forsgren, 478 F.3d 1149, 1160 (10th Cir. 2007).
Because Mr. and Mrs. Meyers are appearing pro se, the court "review[s] [their] pleadings and other papers liberally and hold[s] them to a less stringent standard than those drafted by attorneys." Trackwell v. United States Govt, 472 F.3d 1242, 1243 (10th Cir. 2007) (citations omitted). However, the court may not assume that plaintiffs can prove facts that they have not alleged, or that a defendant has violated laws in ways that plaintiffs have not alleged. See Gallagher v. Shelton, 587 F.3d 1063, 1067 (10th Cir. 2009) (court's role is not to act as the pro se litigant's advocate); Drake v. City of Fort Collins, 927 F.2d 1156, 1159 (10th Cir. 1991) (the court may not "construct arguments or theories for the Plaintiff in that absence of any discussion of those issues").
Defendant argues that Plaintiffs' action is barred by the statute of limitations because the cause of action accrued as early as 2002 and no later than 2008. (Doc. #30). The court's jurisdiction is based on diversity of citizenship. Therefore, Colorado law determines the applicable limitations period. See Guaranty Trust Co. v. York, 326 U.S. 99, 110, 65 S.Ct. 1464, 89 L.Ed. 2079 (1945) (holding that statutes of limitations are considered substantive matters for purposes of the Erie doctrine) (citing Erie Railroad Co. v. Tompkins, 304 U.S. 64 (1938)), overruled on other grounds by Hanna v. Plumer, 380 U.S. 460 (1965). Colorado law requires that actions for failure to instruct or warn be brought within two years after the cause of action accrues. Colo. Rev. Stat. § 13-80-102(1)(b); see Pavelko v. Breg, Inc., No. 09-cv-01461-PAB-KMT, 2011 WL 782664, *4 (D. Colo. Feb. 28, 2011)
Defendant points to Plaintiffs' allegations to demonstrate that Plaintiffs were aware of Mrs. Meyers's alleged injuries and their alleged causal connection to Lipitor as early as 2002, and no later than 2008, when Mrs. Meyer stopped taking the drug. (Doc. #30). Indeed, Plaintiffs allege that the damaging side effects occurred while Mrs. Meyers was taking Lipitor (Doc. # 7), and that Mr. Meyers first noticed signs of adverse effects "within ten days of [her] initially ingesting the prescribed Lipitor." According to Plaintiffs, the side effects abated after Mrs. Meyers ceased taking the drug in 2008. (Doc. #1). Plaintiffs further allege that in September 2010, Mr. Meyers told Defendant Pfizer that his wife had been harmed by the drug (Doc. #1). Plaintiffs initiated this action on October 31, 2014, which is twelve years after Mrs. Meyers began taking Lipitor, six years after she stopped taking the medication, and four years after Mr. Meyers told Defendant Pfizer of Lipitor's deleterious effects. Accordingly, the court finds that Plaintiffs' claim for failure to instruct or warn is barred by the two-year statute of limitations.
Even assuming that the cause of action accrued when the FDA mandated warnings on drugs like Lipitor, this action is still barred.
Plaintiffs do not allege in the Complaint that equitable tolling applies. However, they did raise that issue in their Response to the Order to Show Cause (Doc. #15). Therefore, this court will consider whether equitable tolling applies here.
"Colorado recognizes that `equity may require a tolling of the statutory period where flexibility is required to accomplish the goals of justice.' At the same time, `statutes of limitations compel litigants to pursue their claims in a timely manner.'" Braxton v. Zavaras, 614 F.3d 1156, 1161 (10th Cir. 2010) (quoting Dean Witter Reynolds, Inc. v. Hartman, 911 P.2d 1094, 1096 (Colo.1996)). "[W]hile the statute of limitations is an affirmative defense, when the dates given in the complaint make clear that the right sued upon has been extinguished, the Plaintiff has the burden of establishing a factual basis for tolling the statute." Aldrich v. McCulloch Properties, Inc., 627 F.2d 1036, 1041 n. 4 (10th Cir. 1980).). In practice, however, Colorado courts rarely allow equitable tolling. Escobar v. Reid, 668 F.Supp.2d 1260, 1272 (D. Colo. 2009).
"[T]he exercise of equitable jurisdiction requires an inquiry into the particular circumstances of the case." Garrett v. Arrowhead Imp. Ass'n, 826 P.2d 850, 855 (Colo. 1992). Because the case is time-barred on its face, Plaintiffs have the burden of establishing a factual basis for tolling the statute. Equitable tolling is limited to situations when (1) defendant's wrongful conduct or (2) truly exceptional circumstances prevented the plaintiff from timely filing the claim despite diligent efforts. Noel v. Hoover, 12 P.3d 328, 330 (Colo. App. 2000). Awaiting the result of another case or legal proceeding is not an exceptional circumstance that will equitably toll the statute of limitations. Brodeur v. Am. Home Assur. Co., 169 P.3d 139, 150 (Colo. 2007) Here, there are no allegations of wrongful conduct on the part of Pfizer that prevented Plaintiffs from timely filing their claims, and the court cannot find any "truly exceptional circumstances" in this case that barred Plaintiffs from timely filing their lawsuit despite diligent efforts.
Plaintiffs claim they have done what they could "to bring this problem to a reasonable conclusion." (Doc. #15). Yet the circumstances that prevented Mr. and Mrs. Meyers from timely filing the claim are due entirely to their actions (or inaction). Plaintiffs chose to wait fifteen months after the FDA announcement to bring a pro se claim against Pfizer, despite being aware of the two-year statute of limitations. (Letter from Plaintiff at 1, filed as Doc. #29 in Meyers v. Pfizer, No. 13-cv-1508-WJM-CBS) (Mr. Meyers knew about the two-year statute of limitations, because of the legal advice from two attorneys before the FDA mandate was released). In addition Mr. Meyers chose not to remedy the insufficiencies in his original Complaint. Rather, he stated his desire to dismiss his Complaint in order to refile later without the insufficiencies. Once the court gave him the opportunity to properly file a Notice of Dismissal, the two-year statute of limitations had already passed. None of these events qualify as a "truly exceptional circumstance" under the equitable tolling scenario.
Plaintiffs allege in conclusory fashion and without supporting evidence that Mrs. Meyers's mental state has resembled the early stages of Alzheimer's since 2008. (Doc. #15). Colorado law provides an exception to the statute of limitations based on disability in "actions against a manufacturer or seller of a product . . . for or on account of personal injury . . . caused by or resulting from . . . packaging, labeling, or sale of any product, or the failure to warn or protect against a danger or hazard in the use . . . or the failure to provide proper instructions for the use of any product . . ." Colo. Rev. Stat. § 13-80-106. However, the statute goes on to clearly state:
Colo. Rev. Stat. § 13-80-106(2). This provision clearly excludes Mr. and Mrs. Meyers, because Mrs. Meyers has a spouse, and thus any disability would not affect the accrual of the cause of action.
For the foregoing reasons, this court RECOMMENDS that Defendant's Motion to Dismiss (Doc. #30) be GRANTED and this civil action be dismissed with prejudice.
Within